EE23 Economic Impact of Discontinuation and Relapse Rates Among Patients with Schizophrenia Newly Initiated on Lybalvi Versus Olanzapine during First Year Use
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.330
https://www.valueinhealthjournal.com/article/S1098-3015(23)00430-8/fulltext
Title :
EE23 Economic Impact of Discontinuation and Relapse Rates Among Patients with Schizophrenia Newly Initiated on Lybalvi Versus Olanzapine during First Year Use
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00430-8&doi=10.1016/j.jval.2023.03.330
First page :
Section Title :
Open access? :
No
Section Order :
11716